期刊
NATURE IMMUNOLOGY
卷 22, 期 2, 页码 106-108出版社
NATURE PORTFOLIO
DOI: 10.1038/s41590-020-00842-9
关键词
-
类别
资金
- National Institute of Arthritis Musculoskeletal and Skin Disease grant [R01 AR073311]
- National Institutes of Health
The study demonstrates successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.
A new study shows successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
